Previous close | 12.75 |
Open | 12.75 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 12.75 - 12.75 |
52-week range | 12.75 - 12.75 |
Volume | |
Avg. volume | 0 |
Market cap | 371.566M |
Beta (5Y monthly) | 1.30 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.84 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PARIS, March 22, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announces a final agreement with all its financial creditors on new loan repayment terms.
PARIS, February 22, 2024--CARMAT provides update on the renegotiation of the repayment terms of its loans with its financial creditors
PARIS, February 05, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announces its indicative financial calendar for 2024.